Blood

Published by: American Society of Hematology  

People

  1. Curran
    Curran
  2. Kernan
    Kernan
  3. O'Reilly
    O'Reilly
  4. Sadelain
    Sadelain
  5. Park
    Park
  6. Wang
    Wang
  7. Scaradavou
    Scaradavou
  8. Bernal
    Bernal
  9. Giralt
    Giralt
  10. Kobos
    Kobos

Groups

  1. Pediatrics, Department of (36)
  2. Stem Cell Transplantation and Cellular Therapy Service (36)
  3. Department of Medicine (26)
  4. GSK Faculty (26)
  5. Center for Hematologic Malignancies (24)
  6. Hematologic Malignancies, Division of (22)
  7. Sloan Kettering Institute Faculty (22)
  8. Hematologic Malignancies Research (19)
  9. Adult Leukemia (17)
  10. Tow Center for Developmental Oncology (TCDO) (16)
Search Within
  1. "Kevin Curran"
Formats
  1. Meeting Abstract (31)
  2. Journal Article (4)
  3. Research Letter (1)
Groups
  1. Pediatrics, Department of (36)
  2. Stem Cell Transplantation and Cellular Therapy Service (36)
  3. Department of Medicine (26)
  4. GSK Faculty (26)
  5. Center for Hematologic Malignancies (24)
  6. Hematologic Malignancies, Division of (22)

More Groups

People
  1. Kevin Curran (36)
  2. Renier Brentjens (16)
  3. Isabelle Riviere (15)
  4. Nancy Kernan (15)
  5. Richard O'Reilly (15)
  6. Farid Boulad (13)

More People

Years
  1. 2023 (3)
  2. 2022 (4)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (4)
  6. 2018 (1)

More Years

Publishers
  1. American Society of Hematology (36)

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated results of the phase I BALLI-01 trial of UCART22 Process 2 (P2), an anti-CD22 allogeneic CAR-T cell product manufactured by Cellectis Biologics, in patients with relapsed or refractory (R/R) CD22+ B-cell acute lymphoblastic leukemia (B-ALL)
    Meeting Abstract

    Jain, N.; Chevallier, P.; Liu, H. T.; Schiller, G. J.; Méar, J. B.; DeAngelo, D. J.; Curran, K. J.; Grupp, S.; Baruchel, A.; Balsat, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Risk factors and outcomes for hematotoxicity following tisagenlecleucel for pediatric B-acute lymphoblastic leukemia
    Meeting Abstract

    McNerney, K. O.; Fabrizio, V. A.; Talleur, A. C.; Lim, S. S.; Dreyzin, A.; Baggott, C.; Vatsayan, A.; Rossoff, J.; Prabhu, S.; Pacenta, H. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Obesity associates with inferior outcomes and toxicity in pediatric and young adult patient with relapsed/ refractory B-cell acute lymphoblastic leukemia treated with commercially manufactured tisagenlecleucel
    Meeting Abstract

    Ross, A. J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Philips, C.; Rossoff, J.; Stefanski, H. E.; Talano, J.; Moskop, A.; Baumeister, S. H. C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Standard cytogenetic risk stratification is not predictive of CD19 CAR outcomes and impact of disease burden varies between cytogenetic risk groups
    Meeting Abstract

    Molina, J. C.; Chinnabhandar, V.; Fabrizio, V. A.; Kunicki, M.; Pacenta, H.; Rossoff, J.; Stefanski, H. E.; Talano, J.; Moskop, A.; Verneris, M. R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Antigen directed therapy pre-transplant confers superior post-transplant survival outcome compared to conventional chemotherapy in pediatric patients with relapsed and refractory B-ALL
    Meeting Abstract

    Stiefel, J.; Flower, A. M.; Botwinick, M.; Ford, M.; Foti, A.; Gandhi, M.; Slovin, J.; Smilow, E.; Bowers, A.; Karpel, H.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Peripheral blast count at apheresis acts independent of disease burden as a risk factor for survival following tisagenlecleucel in children and young adults
    Meeting Abstract

    Fabrizio, V. A.; Miller, K.; Baggott, C.; Prabhu, S.; Pacenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H. E.; Talano, J.; Moskop, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia
    Research Letter

    Rossoff, J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Phillips, C. L.; Stefanski, H.; Talano, J. A.; Moskop, A.; Margossian, S. P.; Verneris, M. R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • CD4(+) T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: A dual-center validation
    Journal Article

    de Koning, C.; Prockop, S.; van Roessel, I.; Kernan, N.; Klein, E.; Langenhorst, J.; Szanto, C.; Belderbos, M.; Bierings, M.; Boulad, F.; more...
    Blood (2021)

    Fulltext@MSK | Save

    • Blood – authorized name for:

    Name ISSN / ISBN Publisher
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 2023
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology